Brief: Immucell Announces Change In Timing Of Anticipated FDA Submission
28/06/2023 22:25
ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES CHANGE IN TIMING OF ANTICIPATED FDA
SUBMISSION
* IMMUCELL CORP- HAVE DECIDED TO ADD ONE ADDITIONAL MONTH TO
PROJECTED REGULATORY DEVELOPMENT PROCESS FOR RE-TAIN
Source text for Eikon: ID:nGNXblFRLT
Further company coverage: ICCC.O
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year